Supplemental material
The Clinical Neuropsychologist
Volume 33, 2019 - Issue sup1
Related Research Data
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Source:
American Psychiatric Association Publishing
Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old
Source:
Ovid Technologies (Wolters Kluwer Health)
Detecting At-Risk Alzheimer’s Disease Cases
Source:
IOS Press
Mild cognitive impairment as a diagnostic entity
Source:
Wiley
Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders
Source:
Cambridge University Press (CUP)
Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years
Source:
Taylor & Francis
Performance on the CERAD neuropsychology battery of two samples of Japanese-American elders: norms for persons with and without dementia.
Source:
Cambridge University Press (CUP)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Source:
New England Journal of Medicine (NEJM/MMS)
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Source:
American Psychiatric Association Publishing
Sample Size Requirements for Traditional and Regression-Based Norms
Source:
SAGE Publications
High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients
Source:
Cambridge University Press (CUP)
Accounting for estimated IQ in neuropsychological test performance with regression-based techniques
Source:
Cambridge University Press (CUP)
The consortium to establish a registry for alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of alzheimer’s disease
Source:
Ovid Technologies (Wolters Kluwer Health)
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery
Source:
Ovid Technologies (Wolters Kluwer Health)
A comparison of neuropsychological performance between US and Russia: Preparing for a global clinical trial
Source:
Elsevier BV
When Does Cognitive Functioning Peak? The Asynchronous Rise and Fall of Different Cognitive Abilities Across the Life Span
Source:
SAGE Publications
Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years
Source:
Taylor & Francis
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
Source:
Springer Nature
The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
Source:
Cambridge University Press (CUP)
Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease
Source:
Elsevier BV
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Source:
Wiley
CERAD-neuropsychological battery in screening mild Alzheimer’s disease
Source:
Wiley-Blackwell
Continuous norming: Implications for the WAIS-R
Source:
Wiley
Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study
Source:
Informa UK Limited
Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years
Source:
Elsevier BV
Linking provided by
